- Home
- ABSI vs REFI Comparison
ABSI vs REFI Comparison
Compare ABSI & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABSI | REFI |
|---|---|---|
| Founded | 2011 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 997.8M | 257.7M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ABSI | REFI |
|---|---|---|
| Price | $10.75 | $9.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 5 |
| Target Price | $14.40 | ★ $15.13 |
| AVG Volume (30 Days) | ★ 3.3M | 175.9K |
| Earning Date | 11-11-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 18.76% |
| EPS Growth | ★ 10.64 | N/A |
| EPS | N/A | ★ 0.57 |
| Revenue | $4,534,000.00 | ★ $48,857,628.00 |
| Revenue This Year | $39.03 | $0.76 |
| Revenue Next Year | $314.76 | $7.89 |
| P/E Ratio | ★ N/A | $18.04 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.24 | $9.69 |
| 52 Week High | $12.06 | $13.49 |
Technical Indicators
Market Signals| Indicator | ABSI | REFI |
|---|---|---|
| Relative Strength Index (RSI) | 62.14 | 31.13 |
| Support Level | $8.17 | $9.69 |
| Resistance Level | $11.26 | $10.97 |
| Average True Range (ATR) | 0.71 | 0.25 |
| MACD | 0.16 | -0.10 |
| Stochastic Oscillator | 87.30 | 2.26 |
Price Performance
Historical ComparisonAbout ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. The Company operates as one operating segment, and its primary investment objective is to provide attractive, risk-adjusted returns for stockholders over time, mainly through consistent current income (dividends and distributions) and secondarily, through capital appreciation. The company operates mainly within the USA itself.